• SPX
  • $5,751.07
  • 0.9 %
  • $51.13
  • DJI
  • $42,352.75
  • 0.81 %
  • $341.16
  • N225
  • $38,635.62
  • 0.22 %
  • $83.56
  • FTSE
  • $8,280.63
  • -0.02 %
  • -$1.89
  • IXIC
  • $18,137.85
  • 1.22 %
  • $219.38
Cyclacel Pharmaceuticals, Inc. (CYCC) Competitors

Cyclacel Pharmaceuticals, Inc. (CYCC) Competitors

NASDAQ Currency in USD Disclaimer

Stock Price

$0.91

-$0

(-0.11%)

Day's range
$0.9
Day's range
$0.98

Cyclacel Pharmaceuticals, Inc. Competitors

Symbol Company Share Price Market Cap P/E Ratio Employee Count Revenue
AKTX
Akari Therapeutics, Plc $3.01 $17.67 M -0.71 6 $0
ASMB
Assembly Biosciences, Inc. $14.68 $78.73 M -1.35 65 $7.16 M
CBIO
Catalyst Biosciences, Inc. $0.51 $19.42 M -0.02 7 $794,000
CNTB
Connect Biopharma Holdings Limited $1.41 $108.00 M -1.81 81 $0
CTMX
CytomX Therapeutics, Inc. $1.15 $127.79 M 7.81 120 $101.21 M
CYT
Cyteir Therapeutics, Inc. $3.02 $108.71 M -3.25 46 $0
ELYM
Eliem Therapeutics, Inc. $5.11 $258.33 M -17.08 9 $0
EWTX
Edgewise Therapeutics, Inc. $28.40 $1.65 B -11.47 97 $0
IKNA
Ikena Oncology, Inc. $1.70 $84.45 M -1.11 18 $9.16 M
MBRX
Moleculin Biotech, Inc. $2.43 $9.99 M -0.33 18 $0
NLTX
Neoleukin Therapeutics, Inc. $3.49 $8.20 M -0.28 7 $0
NXTC
NextCure, Inc. $1.34 $38.88 M -0.61 82 $0
OVID
Ovid Therapeutics Inc. $1.15 $210.00 M -4.11 40 $391,695
PTIX
Protagenic Therapeutics, Inc. $0.58 $4.66 M -0.77 1 $0
PULM
Pulmatrix, Inc. $2.10 $7.20 M -0.81 22 $7.30 M
RZLT
Rezolute, Inc. $4.96 $229.57 M -5.02 51 $0
SPRO
Spero Therapeutics, Inc. $1.30 $75.85 M 3.19 46 $96.74 M
TPST
Tempest Therapeutics, Inc. $1.41 $69.10 M -1.81 17 $0
XOMAO
XOMA Corporation $25.59 $283.28 M 25.07 13 $4.76 M
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.